phenoxybenzamine and mdl 100907

phenoxybenzamine has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamik, A; Telegdy, G1
Cao, L; Chen, J; Chen, X; Lou, Z; Qing, J; Rao, Z; Wang, Y; Yang, Y1

Other Studies

2 other study(ies) available for phenoxybenzamine and mdl 100907

ArticleYear
Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats.
    Behavioural brain research, 2015, Mar-15, Volume: 281

    Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Arginine; Atropine; Bicuculline; Dopamine Antagonists; Exploratory Behavior; Haloperidol; Male; Maze Learning; Methysergide; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Nitroso Compounds; Peptide Fragments; Phenoxybenzamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Propranolol; Rats; Rats, Wistar; Receptors, GABA; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Serotonin 5-HT2 Receptor Antagonists

2015
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy.
    Protein & cell, 2019, Volume: 10, Issue:3

    Topics: Animals; Antiviral Agents; Claudin-1; HEK293 Cells; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Mice; Phenoxybenzamine; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Virus Internalization

2019